![Nisha Nanda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Nisha Nanda's former job positions include Senior Director-Clinical Science at Onyx Pharmaceuticals, Inc. from 2012 to 2014, Chief Development Officer at Loxo Oncology, Inc. from 2019 to 2023, and Independent Director at Morphic Holding, Inc. from 2021 to 2024.
Dr. Nanda obtained undergraduate and doctorate degrees from The University of New South Wales.
Former positions of Nisha Nanda
| Companies | Position | End |
|---|---|---|
| MORC HOLD | Director/Board Member | 2024-08-15 |
| LOXO ONCOLOGY INC | Corporate Officer/Principal | 2023-04-30 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Corporate Officer/Principal | 2014-01-31 |
Training of Nisha Nanda
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
40
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
Morphic Holding, Inc.
 Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
- Stock Market
- Insiders
- Nisha Nanda
